Laura Guarga

Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut)

Laura Guarga, Xavier Badía, Mercè Obach et al. · Orphanet Journal of Rare Diseases · 2019 · 72 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +15

Trends in lung cancer incidence by age, sex and histology from 2012 to 2025 in Catalonia (Spain)

Laura Guarga, Alberto Ameijide, Rafael Marcos‐Gragera et al. · Scientific Reports · 2021 · 31 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Application Of Multi-Criteria Decision Analysis (MCDA) To Determine The Value Of Treatments For The Moderate To Severe Plaque Psoriasis In Spain

Xavier Badía, P. de la Cueva, F Rodríguez Moreda et al. · Value in Health · 2017 · 21 citations · Full text

Business, Decision Sciences, Dermatology +12

Patient involvement in reflective multicriteria decision analysis to assist decision making in oncology

Xavier Badía, Alfonso Aguarón, Ana Fernández et al. · International Journal of Technology Assessment in Health Care · 2019 · 19 citations

Medicine, Oncology, Medical Oncology +14

Implementing Risk-Sharing Arrangements for Innovative Medicines: The Experience in Catalonia (Spain)

Laura Guarga, M. Joana Virgili Gasol, Anna Reyes et al. · Value in Health · 2021 · 12 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +15